C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2004
11/10/2004	CN1544616A Vibrio and process for producing mannuronic acid lyase by using the same
11/10/2004	CN1544615A Vibrio and process for producing guluronicacid lyase by using the same
11/10/2004	CN1175108C Method for production of L-amino acids from their racemic N-acetyl-D,L-derivatives by enzymatic separation of recombinant enzymes
11/10/2004	CN1175107C DNA molecules of encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutant thereof
11/10/2004	CN1175105C Purification of vitamin-K dependent proteins by membrane chromatography
11/10/2004	CN1175104C Endo-beta-N-acetyl glucosaminidase gene
11/10/2004	CN1175103C Preparation method of angiotensin converting enzyme inhibitor affinity column medium
11/09/2004	US6815581 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/09/2004	US6815580 To improve plant yield by increasing starch biosynthesis; located in chloroplasts in leaves/stems
11/09/2004	US6815579 Condensing enzyme/fatty acid elongase such as beta-ketoacyl-coenzyme a synthase 2 (kcs2); for production of lubricants/nylon/cosmetics/pharmaceuticals/plasticizers from erucic acid
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815532 For use in cancer therapy
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815196 Nucleic acids coding enzymatic polypeptide for use in the generation of amino acids for use in animal nutrients
11/09/2004	US6815195 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids
11/09/2004	US6815194 Cytidine deaminase
11/09/2004	US6815193 Protease for use in treating textiles, cleaning agents and animal feeds
11/09/2004	US6815192 Enzymatic polypeptide for use in detergents and textile processing
11/09/2004	US6815191 Endo-β-N-acetylglucosaminidase gene
11/09/2004	US6815190 Having improved thermostability; used in the enzymatic hydrolysis of cyclic oligomers of poly(ethylene terephthalate) in the finishing of yarn or fabric from fibers
11/09/2004	US6815189 For the synthesis of deacetylated derivatives; gene expression inhibition
11/09/2004	US6815188 Human kinases and polynucleotides encoding the same
11/09/2004	US6815186 Implantable glucose sensor
11/09/2004	US6815184 Generating preferential polypeptide in plant; obtain plant cells, transform with vector containing preferential polypeptide, express vector, recover polypeptide
11/09/2004	US6815183 For preventing infection of mosquitoes/transmission of malaria; drug screening; vaccines
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815174 For diagnosis of insulin dependant diabetes mellitus; detecting antibodies in human serum using esherichia coli proteins
11/09/2004	US6815159 Generation of viral protease; obtain polypeptide, incubate with chaotropic agent, fold, recover protease
11/09/2004	US6814962 Defective recombinant adenovirus comprising a nucleic acid sequence coding for a biologically active human lipoprotein lipase
11/09/2004	CA2304437C Process for the production of naturally folded and secreted proteins
11/09/2004	CA2294475C Recombinant materials and methods for the production of limonene hydroxylases
11/09/2004	CA2151231C Human cyclooxygenase-2cdna and assays for evaluating cyclooxygenase-2 activity
11/09/2004	CA2035381C Preparation and use of gene banks of human antibodies ("human-antibody libraries")
11/04/2004	WO2004094674A1 Method of inactivating ribonucleases at high temperature
11/04/2004	WO2004094641A2 A novel method of modulating bone-realted activity
11/04/2004	WO2004094638A1 Vasculitis antigen and method of diagnosing vasculitis
11/04/2004	WO2004094631A1 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/04/2004	WO2004094630A1 Insect chymotrypsin and inhibitors thereof
11/04/2004	WO2004094629A1 Human alkaline sphingomyelinase and use thereof
11/04/2004	WO2004094601A2 Methods of treating pin1 associated disorders by covalent modification of active site residues
11/04/2004	WO2004094593A2 Expanding the eukaryotic genetic code
11/04/2004	WO2004094478A2 Cleavage of fusion proteins using granzyme b protease
11/04/2004	WO2004094463A2 Peptide inhibitors of autophosphorylation protein kinases
11/04/2004	WO2004094402A1 NOVEL SUBSTANCE HAVING α-GLUCOSIDASE INHIBITING ACTIVITY AND FOOD CONTAINING THE SAME
11/04/2004	WO2004094344A2 Methods for production of recombinant urokinase
11/04/2004	WO2004093919A2 Target for cancer therapy and drug discovery
11/04/2004	WO2004093877A1 Vitamin comprising pyroloquinoline quinone and use thereof
11/04/2004	WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
11/04/2004	WO2004093787A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
11/04/2004	WO2004093645A2 Tn5 transposase mutants and the use thereof
11/04/2004	WO2004093532A2 Generation of plants with altered oil content
11/04/2004	WO2004093524A2 Oxygen-resistant hydrogenases and methods for designing and making same
11/04/2004	WO2004083362A3 Modification of subtilases using protein modelling based on the jp170 three-dimensional structure
11/04/2004	WO2004083361A3 FVII OR FVIIa VARIANTS
11/04/2004	WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004	WO2004064870A8 Radiolabelled tissue factor binding agent and the use thereof
11/04/2004	WO2004057001A3 Method for the production of polyunsaturated fatty acids
11/04/2004	WO2004050883A3 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2003104422A3 Mahoganoid polypeptides, and related compositions and methods
11/04/2004	WO2003102209A3 Alternatively spliced isoforms of human hmg co-a reductase
11/04/2004	WO2003102200A3 Fermentation process using specific oxygen uptake rates as a process control
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003093482A3 Method for producing multiple unsaturated fatty acids in plants
11/04/2004	WO2003092612A3 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/04/2004	WO2003091403A3 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/04/2004	WO2003055981A3 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
11/04/2004	WO2002070675A3 Regulation of human histone acetyltransferase
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040221335 Transforming plant with expression vector comprising nucleotide sequences coding fatty acid desaturase; for use in enhancing concentration of fatty acid in crop plants; tissue engineering and heterologous gene expression; enhancing nutrients of animal feeds
11/04/2004	US20040221331 Male tissue-preferred regulatory sequences of Ms45 gene and method of using same
11/04/2004	US20040220394 Nucleotide sequences which code for the eno gene
11/04/2004	US20040220387 Allelic nucleotide sequences for diagnosis and prognosis of bipolar affective disorder; restriction fragment length polymorphisms and disease detection
11/04/2004	US20040220385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/04/2004	US20040220383 Methods and materials relating to semaphorin-like polynucleotides
11/04/2004	US20040220132 Treatment of neurodegenerative disease through intracranial delivery of siRNA
11/04/2004	US20040220130 Compact synthetic expression vector comprising double-stranded DNA molecules and methods of use thereof
11/04/2004	US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004	US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	US20040219677 Synthetic genes and bacterial plasmids devoid of cpg
11/04/2004	US20040219673 Expression vector which utilizes site specific recombinases as insertion tools during in vivo and/or in vitro gene transfer
11/04/2004	US20040219656 Novel antibacterial and herbicidal compounds and system for screening the same
11/04/2004	US20040219654 Novel pyruvate decarboxylase, production and use thereof
11/04/2004	US20040219652 Enzyme mixture comprising cellulase, xylanase and laccase for degrading waste deposit from animal skins and cleaning farm buildings; leather working
11/04/2004	US20040219650 Hydrolyzing the materials in an anaerobic vessel, transferring the liquid product of hydrolysis to an anaerobic digester, and further decomposing the waste materials under aerobic conditions to yield a compost
11/04/2004	US20040219649 Using granular starch incubated with yeast in heated enzyme mix to generate/ferment fuel, potable and/or industrial ethanol
11/04/2004	US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004	US20040219638 Nucleic acids encoding beta 1,3-galactosyltransferases from C.jejuni
11/04/2004	US20040219636 Aminopeptidase and the genes thereof
11/04/2004	US20040219634 Hybrid telomerase for generating gene transfer vector; gene therapy
11/04/2004	US20040219631 Method for producing tripeptides and/or peptides longer than tripeptides
11/04/2004	US20040219609 Methods for modulating proteins not previously known as proteases
11/04/2004	US20040219600 Using glutathione-s-transferase expression as diagnostic indicator of nervous system disorders and neurotoxicity; immmunoassay;
11/04/2004	US20040219594 stereoselective hydrolase for mass production using genetically engineered escherichia; for use in preparation of enantiomeric non-steroidal anti-inflammatory drugs for treatment of cancer, hypertension and alzheimer's diseases; gel chromatography
11/04/2004	US20040219584 Using genetic engineering to prepare catalytic fusion protein comprising both cleavage and methylase domains; enhancing restriction enzyme specificity
11/04/2004	US20040219583 Using splice variants of prostate specific antigen as diagnostic indicator of cell proliferative disorders
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219561 Phytic acid biosynthetic enzymes

1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 1416